pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 29·1 min read
save

XPRIZE Healthspan launches $101 million competition to test anti-aging therapies in older adults

May 29, 2026·read at STAT ↗Positive

Jamie Justice, former Wake Forest professor, now leads XPRIZE Healthspan, a global contest aimed at finding treatments that can restore muscle, cognition and immune function in older people.

The competition offers a $101 million prize pool. Ten teams were chosen from a field of forty this year and must conduct year‑long randomized controlled trials before a winner is named in 2030.

Participants are pursuing diverse strategies, from exercise programs to senolytic drugs that clear damaged cells, reflecting the broad interest in slowing the aging process and the need for rigorous evidence of efficacy.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: The woman behind the world’s biggest longevity competition”

read at STAT ↗
641 words · retrieved Jun 3
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLYWake Forest University
drugs
Ebola vaccinePLUVICTOlutetium Lu 177 vipivotide tetraxetan
topics
Immunology2Radioligand TherapyVaccine

related stories

  • Jun 3Senior NIH scientist, research fellow charged with bringing deactivated mpox virus into U.S.STAT
  • Sep 21Telix buys ITM for $1.65B in ‘supercritical’ radiopharma M&ABioSpace
  • Sep 11Novartis’ board faces investor scrutiny after M&A misfires and R&D flopsBioSpace
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT
  • Aug 25Preparing for Novartis showdown, Curium touts value of radiopharma supply resiliencyBioSpace